ACCESSWIRE

ZeptoMetrix, an Antylia Scientific Company

Share
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials

TRONDHEIM, NORWAY / ACCESSWIRE / April 9, 2024 / Chiron AS, now part of ZeptoMetrix®, has developed the world's very first commercially available microplastic reference materials. This revolutionary new product range, called MicroPRefs®, was developed in close collaboration with the Norwegian Institute for Water Research (NIVA) and was made possible by grants from the EU project EUROqCHARM and Innovation Norway.

To view this piece of content from cdn.nwe.io, please give your consent at the top of this page.
Chiron by ZeptoMetrix



Microplastic particles are found in large quantities in water, soil, and in the air. Plastic pollution of various kinds breaks down in nature into tiny particles. These range in size from macro- to nano-sized particles. Microplastics are also carriers of various environmental toxins such as PFAS (per- and poly-fluoroalkyl substances) and brominated flame retardants, and cause significant environmental and health risks to communities around the world.

"In order to measure the quantity and type of microplastic substances present, there is a need for a yardstick or a 'reference material,' which is a material developed in the laboratory that can be used for comparison. ZeptoMetrix's Chiron AS business has now developed the very first commercially available microplastic reference materials for the six most abundant plastics in nature. New variants will follow successively throughout this year," stated Huiling Liu, Ph.D., Senior Director, R&D Analytical Reference Materials.

MicroPRefs® microplastic reference materials feature a novel tablet format containing a defined number of particles. The particles produced are of known plastic type and were designed to provide sizes and shapes that mimic microplastics found in nature. The tablets are dissolved in water and then analyzed using various methods and in parallel with real samples from nature.

The first single polymer tablets produced contain microplastic particles ranging in size between 50 and 300 micron. Multi-polymer tablets contain a mixture of three different plastic types. Further variants containing different size, quantity and combinations of plastics are planned to support researchers in their endeavors.

"The need to monitor microplastics in our surroundings is paramount to protecting the ongoing health of our communities. ZeptoMetrix is committed to fostering innovations that will help solve real-world issues as laboratories around the world can now deliver microplastics test results with greater confidence," stated Evangeline Gonzalez, President of ZeptoMetrix. "In addition, our scientists are partnering with industry organizations and leading laboratories to incorporate microplastics into our innovative proficiency testing programs."

About ZeptoMetrix
Chiron AS is part of ZeptoMetrix®, an Antylia Scientific company. ZeptoMetrix is the industry leader and manufacturer for innovative solutions solving challenges in the evolving Diagnostic Microbiology, Infectious Disease, and Oncology markets, as well as Analytical Reference Materials for the Applied Markets. We focus on our customers' success by providing premium product quality, reliability, and expert technical knowledge, enabling our customers to develop and advance many applications across diagnostics, pharmaceutical, environmental, food and beverage industries. From in-stock solutions to custom control and panel development, our scientific teams provide our customers with comprehensive, performance-oriented, and cost-effective products and services that positively impact the field of clinical diagnostics, analytical testing and contribute to a healthier world. ZeptoMetrix is a division of Antylia Scientific, an operating company of premier life science and diagnostic brands, including Cole-Parmer, Environmental Express and ZeptoMetrix.

Contact Information
Nancie Geddings
Global Business Development Leader
nancie.geddings@antylia.com
1-843-277-5230

Related Files

Chiron AS Develops the World's First Commercial Microplastic Reference Materials

SOURCE: ZeptoMetrix

To view this piece of content from stats.nwe.io, please give your consent at the top of this page.

View the original press release on newswire.com.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESSWIRE

DK

Subscribe to releases from ACCESSWIRE

Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESSWIRE

Accurate Background Partnering with Konfir to Provide Fast, Secure Instant Employment Verification in the United Kingdom5.12.2024 09:15:00 CET | Press release

IRVINE, CA / ACCESSWIRE / December 5, 2024 / Accurate Background, headquartered in Irvine, CA, and the largest privately held and minority-owned global provider of compliant background checks, drug and health screening, and workforce monitoring solutions, has announced a new partnership with Konfir, an innovative company providing employment verification technology in the UK. This collaboration will provide Accurate's clients access to Konfir's real-time verification tools via Accurate technology. Accurate's integration of Konfir's instant employment verification API will allow candidates to aggregate real-time data from multiple data sources including Payroll, HMRC, and Open Banking, streamlining screening processes and reducing time-to-hire. In addition, Accurate will now offer enhanced fraud mitigation tools through Konfir's suite of insights helping employers identify potential hiring risks more effectively. Kevin Stone, Sales & Marketing Director at Accurate, commented: "At Accura

CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 20245.12.2024 09:10:00 CET | Press release

Live webcast discussion featuring internationally renowned Glioblastoma Multiforme (GBM) Key Opinion Leaders Company committed to addressing the most aggressive type of brain cancer with an average survival of only 14 to 16 months after diagnosis and no cure Register for the event here HOUSTON, TX / ACCESSWIRE / December 5, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced it will host a Virtual Analyst & Investor Day on Wednesday, December 11th from 11:30 AM - 1:00 PM ET. For the event, John Climaco, Chief Executive Officer, Sandra Silberman, MD, PhD, Chief Medical Officer and Zena Muzyczenko, Vice President of Clinical Operations at CNS Pharmaceuticals will be joined by Key Opinion Leaders: Michael Weller, Prof. Dr. med. Director of Department, Department of Neurology, Universitatsspital, Zur

Atha Energy Identifies Numerous Outcrops Hosting High-Grade Uranium Mineralization5.12.2024 07:00:00 CET | Press release

HIGHLIGHTS Surficial mapping was conducted as part of the 2024 Angilak Exploration Program that focused on areas strictly proximal to the Lac 50 Deposit and achieved its objective of discovering high-grade uranium mineralization on surface beyond the extents of the Lac 50 Deposit's Exploration Target Model; High-grade surficial uranium mineralization was identified between Lac 48, Lac 50, Lac 52, and Lac 54 trends, collectively known as the Lac 50 Deposit, along prospective new parallel trends; Discovery of outlined outcrops containing high-grade uranium mineralization along strike from the Lac 50 Deposit provide basis for future exploration and significantly de-risk expansion efforts; A zone of extensive bedrock outcrop with radioactivity up to >60,000 counts per second (cps) - >10,000 cps is indicative of high-grade uranium mineralization - was identified over a 3-kilometre strike length. The new discovery is located between the Mushroom Lake zone on the Lac 52 trend and the Hot zone

TACACS.net: Strengthening Network Security with Native Active Directory Integration4.12.2024 16:55:00 CET | Press release

The Weakest Link in Cybersecurity: Addressing Authentication Vulnerabilities SAN JOSE, CA / ACCESSWIRE / December 4, 2024 / In an era where 75% of security breaches are attributed to weak authentication, the importance of robust cybersecurity measures has never been greater. Recognizing this critical need, TACACS.net has emerged as the #1 choice for Active Directory (AD) integration, offering unmatched reliability, performance, and security. Authentication is often the weakest link in network security. If a hacker cannot authenticate to a device, they cannot exploit it. TACACS.net addresses this vulnerability by delivering a solution built to meet the needs of modern organizations, ensuring fast, secure, and seamless integration with existing infrastructure. Why TACACS.net Stands Out Most organizations rely on Active Directory to manage users, but competing solutions depend on middleware-complex intermediaries that often fail, usually at the worst possible time. TACACS.net is the only

Polaris Renewable Energy Successfully Settles USD 175 Million Bond Issue4.12.2024 16:05:00 CET | Press release

TORONTO, ON / ACCESSWIRE / December 4, 2024 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris" or the "Company") announces that it has successfully settled a previously announced private placement of USD 175 million senior secured green bonds. The bonds will have a tenor of five years and a fixed coupon rate of 9.5% percent per annum, with interest payable in semi-annual instalments. Furthermore, the Green Bond will include a tap feature, allowing for access to an additional USD $50 million in funding for potential future uses. The bond issue is rated BB- by S&P Global Ratings and is issued under the Company's green finance framework with second-party opinion from Morningstar Sustainalytics. Marc Murnaghan, Chief Executive Officer of Polaris comments: "We are very pleased to successfully settle this inaugural bond issue with strong interest from a wide set of international investors. The bond optimizes the Company's capital structure and secures financing for further growth and incre

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye